“Drug Design Facilitated by AI, MD, Objective Facts, and Clinical Feedback”

Next week’s #WebinarWednesday features Dr. Lee-Wei Yang, a computational structural biologist and theoretical physical chemist whose work spans Taiwan, Korea, the U.S., and Japan.

In his talk, “Drug Design Facilitated by AI, MD, Objective Facts, and Clinical Feedback,” Dr. Yang explores why AI-driven drug discovery has yet to consistently translate into clinical success—and how a feedback-informed approach could change that. By integrating generative AI, molecular dynamics, and clinical data, his lab has developed ADC-like small molecules (ALSMs) that show promise for targeted, low-toxicity therapeutics with broader applications.

Dr. Yang is a professor at National Tsing Hua University and Academia Sinica, and currently a researcher at Ewha Womans University’s Global AI Drug Discovery Center. His work has been published in Nature Communications, Nature Methods, Nucleic Acids Research, and other leading journals.

The webinar will take place on 25 June 2025, Wednesday, at 9:00 AM PHT via Zoom.

Register now at tinyurl.com/UPISCWebinarsJune2025.

For questions, email [email protected].

We hope to see you there!

Source: University of the Philippines Intelligent Systems Center Facebook